Video
Author(s):
Pashna Munshi, MD, discusses how acute GVHD is staged and graded, and the common frontline treatment options.
DK210 (EGFR) Induces Immune Response Without Increased CRS or Regulatory T Cells in Solid Tumors
Siglec-15 Represents Potential Therapeutic Target in NSCLC, Other Solid Tumors
Radiomic Biomarkers Predict Response in Lung and Liver Uveal Melanoma Metastases
BT7480 Shows Preliminary Activity in Nectin-4+, CD137+ Tumors
2 Commerce Drive
Cranbury, NJ 08512